DEMYELINATING DISEASE: Is TOPIC the last trial for clinically isolated syndrome?

    loading  Checking for direct PDF access through Ovid


The recent TOPIC trial found that teriflunomide could prevent relapses in patients with clinically isolated syndrome (CIS). Many other multiple sclerosis (MS) therapies are effective for CIS, because CIS is the first clinical manifestation of MS for most patients. Questions remain over the utility of future trials like TOPIC.

    loading  Loading Related Articles